Trexquant Investment LP Silence Therapeutics PLC Transaction History
Trexquant Investment LP
- $8.06 Billion
- Q4 2024
A detailed history of Trexquant Investment LP transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Trexquant Investment LP holds 63,663 shares of SLN stock, worth $286,483. This represents 0.01% of its overall portfolio holdings.
Number of Shares
63,663Holding current value
$286,483% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding SLN
# of Institutions
76Shares Held
28.1MCall Options Held
300Put Options Held
2K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$13.7 Million7.16% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$12.7 Million2.57% of portfolio
-
Redmile Group, LLC San Francisco, CA1.9MShares$8.55 Million2.26% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$8.35 Million1.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.15MShares$5.17 Million1.12% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $161M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...